5981 - 5990 of 7939 Results
Title
Year
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 12
- Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s disease2017OPENTitle: Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-04254-yBest OA location URL: https://doi.org/10.1038/s41598-017-04254-yCitation Count: 21
-
OPENTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://europepmc.org/articles/pmc5656509?pdf=renderCitation Count: 138
- An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients2017OPENTitle: An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease PatientsJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 34Issue #: 7Start Page: 1741End Page: 1752Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12325-017-0571-2Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs12325-017-0571-2.pdfCitation Count: 24
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 93
- Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts2017OPENTitle: Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohortsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 8Start Page: 620End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(17)30122-9Best OA location URL: http://manuscript.elsevier.com/S1474442217301229/pdf/S1474442217301229.pdfCitation Count: 155
-
RESTRICTEDTitle: BCL-2 family: integrating stress responses at the ER to control cell demiseJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 24Issue #: 9Start Page: 1478End Page: 1487Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/cdd.2017.82Best OA location URL: https://www.nature.com/articles/cdd201782.pdfCitation Count: 188
- Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity2017OPENTitle: Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0021-5Best OA location URL: https://www.nature.com/articles/s41531-017-0021-5.pdfCitation Count: 38
-
OPENTitle: Neuropathologic features of TOMM40 '523 variant on late‐life cognitive declineJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 12Start Page: 1380End Page: 1388Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.05.002Best OA location URL: https://europepmc.org/articles/pmc5723540?pdf=renderCitation Count: 17
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates2017OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 37